Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line
- 26 August 2003
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 309 (2), 377-383
- https://doi.org/10.1016/j.bbrc.2003.08.012
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortalityCancer, 2010
- Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian CancersGynecologic Oncology, 2003
- Induction of ovarian cancer by defined multiple genetic changes in a mouse model systemCancer Cell, 2002
- Development of a syngeneic mouse model for events related to ovarian cancerCarcinogenesis: Integrative Cancer Research, 2000
- Focal Adhesion Kinase Overexpression Enhances Ras-dependent Integrin Signaling to ERK2/Mitogen-activated Protein Kinase through Interactions with and Activation of c-SrcOnline Journal of Public Health Informatics, 1997
- Lipopolysaccharide inhibits rat ovarian thecal-interstitial cell steroid secretion in vitro.Endocrinology, 1995
- Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinaseNature, 1994
- Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.Molecular and Cellular Biology, 1994
- Cell growth regulation in epithelial ovarian cancerCancer, 1993
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences of the United States of America, 1980